Molecular basis of differential 3′ splice site sensitivity to anti-tumor drugs targeting U2 snRNP

Several families of natural compounds target core components of the pre-mRNA splicing machinery and display anti-tumor activity. Here the authors show that particular sequence features can be linked to drug response, and that drugs with very similar chemical structures display substantially differen...

Full description

Bibliographic Details
Main Authors: Luisa Vigevani, André Gohr, Thomas Webb, Manuel Irimia, Juan Valcárcel
Format: Article
Language:English
Published: Nature Publishing Group 2017-12-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-017-02007-z